Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Robotic Partial Nephrectomy Outcomes Evaluated

BJU Int; ePub 2017 Dec 12; Xia, Pulido, et al

People with renal cell carcinoma (RCC) who undergo robot-assisted partial nephrectomy (RAPN) at higher volume hospitals appear to experience better perioperative outcomes and have lower rates of positive surgical margin, according to a study involving nearly 19,000 individuals. Participants with RCC underwent RAPN between 2010 and 2013. Investigators grouped cases into very low-, low-, medium-, high-, and very high-volume categories, and evaluated certain outcomes. Among the results:

  • There were no significant differences in 30- and 90-day mortality rates across groups.
  • Patients at very high-volume centers were 53% less likely to experience open conversion than those at very low-volume centers.
  • Patients at high-, medium-, and low-volume centers were also less likely to experience conversion (43%, 40%, and 12%, respectively)
  • Those at very high-, high-, medium-, and low-volume centers were less likely to experience prolonged length of stay (55%, 38%, 25%, and 7%, respectively).
  • They were also less likely to experience positive surgical margin (66%, 41%, 24%, and 24%, respectively).

Citation:

Xia L, Pulido J, Chelluri R, et al. Hospital volume and outcomes of robot-assisted partial nephrectomy. [Published online ahead of print December 12, 2017]. BJU Int. doi:10.1111/bju.14099

This Week's Must Reads

Liquid biopsy aids assessment in advanced imatinib-resistant GIST, George S et al. ASCO 2018. Abstract 11511.

Rapid therapy changes fall short for metastatic GIST, Serrano-Garcia C et al. ASCO 2018, Abstract 11510.

Estimated conditional OS shows upfront TKI benefit in mRCC, Kang M et al. J Urol. 2018 June 22. doi: 10.1016/j.juro.2018.06.030

Indolent course found in rare clear cell papillary RCC , Chen W-J et al. J Chinese Med Assoc. 2018 July 20 doi: 10.1016/j.jcma.2018.04.005

Must Reads in Renal Cell Carcinoma

Estimated conditional OS shows upfront TKI benefit in mRCC, Kang M et al. J Urol. 2018 June 22. doi: 10.1016/j.juro.2018.06.030

Indolent course found in rare clear cell papillary RCC , Chen W-J et al. J Chinese Med Assoc. 2018 July 20 doi: 10.1016/j.jcma.2018.04.005

Study: Clear cell papillary RCC has indolent course, Chen W-J et al. J Chinese Med Assoc. 2018 July 20 doi: 10.1016/j.jcma.2018.04.005

Some ccRCC subtypes associated with CT features, Bowen L, Xiaojing L. Acad Radiol. 2018 Jul 29. doi: 10.1016/j.acra.2018.05.002

GAG measurements offer prognostic info for RCC, Gatto F et al. Eur Urol Oncol. 2018 Jun 13. doi: 10.1016/j.euo.2018.04.015